semaglutide pregnancy studies Study links GLP-1 use to some risks — but the research has key caveats Semaglutide Use During Pregnancy

Researchers analyze DSIP to better understand how peptides influence neurotransmitters and central nervous system activity

This page is written for research-only interpretation and does not provide dosing, clinical, diagnostic, therapeutic, veterinary, or human-use guidance

Most people need a plan to maintain results. Long-term success comes from a combination of: Medication (when needed) Nutrition habits Muscle-preserving exercise Metabolic follow-ups Lifestyle coaching Patients who stop suddenly and stop these supportive habits typically regain the most weight

Independence Blue Cross (Pennsylvania) excluded Wegovy for fully insured group and individual plans effective January 1, 2025

Polymeric delivery systems for nucleic acid therapeutics: approaching the clinic